173 Episodo

  1. Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing

    Publicado: 7/6/2022

  2. Ep114: Chris Gibson on Industrializing Drug Discovery

    Publicado: 23/5/2022

  3. Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs

    Publicado: 9/5/2022

  4. Ep112: Bernat Olle on Microbiome Therapeutics

    Publicado: 18/4/2022

  5. Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery

    Publicado: 14/3/2022

  6. Ep110: Michele Andrasik on Making Clinical Trials More Diverse

    Publicado: 1/3/2022

  7. Ep109: Derrell Porter on Cell Therapy Commercialization

    Publicado: 15/2/2022

  8. Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules

    Publicado: 31/1/2022

  9. Ep107: Bassil Dahiyat on Antibody Engineering & Company Building

    Publicado: 11/1/2022

  10. Ep106: Vineeta Agarwala on Health Data & VC Investing

    Publicado: 20/12/2021

  11. Ep105: Nello Mainolfi on Targeted Protein Degraders

    Publicado: 6/12/2021

  12. Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity

    Publicado: 1/12/2021

  13. Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer

    Publicado: 23/11/2021

  14. Ep102: David Baltimore Reflects on a Life in Science

    Publicado: 8/11/2021

  15. Ep101: Tony Kulesa on Fostering Founder-Led Biotechs

    Publicado: 26/10/2021

  16. Ep100: Christian Henry on Long Read DNA Sequencing

    Publicado: 13/10/2021

  17. Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations

    Publicado: 27/9/2021

  18. Ep98: Mara Aspinall on Diagnostics and COVID-19

    Publicado: 13/9/2021

  19. Ep97: John Evans on Base Edited Therapeutics

    Publicado: 7/9/2021

  20. Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids

    Publicado: 9/8/2021

4 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site